Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Flexion Therapeutics, Inc.
  6. Summary
    FLXN   US33938J1060

FLEXION THERAPEUTICS, INC.

(FLXN)
 SummaryQuotesChartsNewsRatingsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2019 73,0 M - -
Net income 2019 -150 M - -
Net Debt 2019 65,8 M - -
P/E ratio 2019 -5,26x
Yield 2019 -
Sales 2020 85,6 M - -
Net income 2020 -114 M - -
Net Debt 2020 56,0 M - -
P/E ratio 2020 -4,57x
Yield 2020 -
Capitalization 459 M 459 M -
EV / Sales 2019 11,7x
EV / Sales 2020 7,31x
Nbr of Employees -
Free-Float 95,6%
More Financials
Company
Flexion Therapeutics, Inc is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), the common form of arthritis. Its product candidate, ZILRETTA, is the intra-articular (IA) injection indicated for the management of OA knee pain. It is approved by Food and... 
Read more
More about the company
Ratings of Flexion Therapeutics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about FLEXION THERAPEUTICS, INC.
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,..
MT
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
CI
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
PR
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021FLEXION THERAPEUTICS : HC Wainwright Downgrades Flexion Therapeutics to Neutral From Buy, ..
MT
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
More news
News in other languages on FLEXION THERAPEUTICS, INC.
2021Les actions du secteur de la santé en baisse lundi en fin de journée
2021Flexion Therapeutics accepte d'être rachetée par Pacira BioSciences ; les actions s'env..
2021Pacira achète Flexion pour 427,5 millions de dollars
2021Pacira achète Flexion pour 427,5 millions de dollars
2021Earnings Flash (FLXN) FLEXION THERAPEUTICS annonce un chiffre d'affaires de 28,2 millio..
More news
Analyst Recommendations on FLEXION THERAPEUTICS, INC.
More recommendations
Chart FLEXION THERAPEUTICS, INC.
Duration : Period :
Flexion Therapeutics, Inc. Technical Analysis Chart | FLXN | US33938J1060 | MarketScreener
Income Statement Evolution
Managers and Directors
Carolyn Beaty Scimemi Chief Compliance Officer & Head-Legal Affairs
Scott A. Young VP-Corporate Communications & Investor Relations
Sector and Competitors
1st jan.Capi. (M$)
FLEXION THERAPEUTICS, INC.-20.97%459
GILEAD SCIENCES, INC.-1.16%90 027
REGENERON PHARMACEUTICALS, INC.-2.58%64 327
VERTEX PHARMACEUTICALS INCORPORATED6.58%59 510
WUXI APPTEC CO., LTD.-3.88%52 722
BIONTECH SE-23.97%47 338